Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000541509 | SCV000653583 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456240 | SCV002617618 | likely benign | Inborn genetic diseases | 2022-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003437275 | SCV004151000 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | RTEL1: BP4, BP7, BS1, BS2; RTEL1-TNFRSF6B: BS1, BS2 |
Laboratory of Diagnostic Genome Analysis, |
RCV001573827 | SCV001800239 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001573827 | SCV001954872 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001834809 | SCV002095562 | likely benign | Dyskeratosis congenita | 2019-12-13 | no assertion criteria provided | clinical testing |